Under construction – not a live service
Sign in
Taking people in FranceNo phase

Personalized 6-month programme for frailty in older people with bladder or kidney cancer

Tests an exercise and education programme against frailty in older bladder or kidney cancer patients.

Key facts

Who runs it
Centre Hospitalier Universitaire de Saint Etienne
Where
Saint-Etienne, FranceSee the 2 sites
Trial code
Registry title
Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.
Status
Recruiting
People taking part
106 people, planned
Started
3 Dec 2025
Expected to end
Mar 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • APA
  • Therapeutic education workshops
  • DAPAP
Record updated
9 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 65 and older with bladder or kidney cancer who are about to have surgery. It tests a 6-month personalized programme before and after surgery.

Age
65 years and older
Sex
All sexes can join
Disease stage
Bladder or kidney cancer treated with surgery; surgery must not be done yet
Earlier treatment
Surgery must not already be done. People already on a prehabilitation prescription with a private physiotherapist cannot join.

Main reasons for not taking part

  • Surgery already done
  • Other health problems that make physical activity unsafe, such as heart disease, lung disease or disabling joint disease
  • Severe cognitive impairment that prevents understanding the study
  • Deprived of liberty or under guardianship
  • Already on a prehabilitation prescription with a private physiotherapist

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosis of bladder or kidney cancer
  • Surgical treatment
  • No severe cognitive impairment preventing understanding of the protocol
  • Affiliated or entitled to a social security scheme
  • Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study

Who cannot take part

  • Surgery already done
  • Significant co-morbidities that contraindicate physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies, etc
  • Deprived of liberty or under guardianship
  • Benefiting from a prehabilitation prescription with a private physiotherapist

Where in France

  • CHU Saint-EtienneSaint-Etienne, FranceContact: David HUPIN, MDTaking people
  • Hôpital privé de la LoireSaint-Etienne, FranceContact: Emilie FAVIER, MDNot yet recruiting

About the trial

What the trial wants to find out

Bladder and kidney cancers are commonly diagnosed in older adults. Surgery remains the primary treatment modality for patients with kidney or bladder cancer. In older patients, common co-morbidities include fatigue, physical deconditioning characterized by reduced cardiorespiratory fitness and progressing sarcopenia, pain- whether disease- related or treatment-induced- and undernutrition. These factors increased the risk of post-operative complications and exacerbate patient frailty.

Read full original descriptionShow less

The investigators propose a personalized 6-month program both pre- and post-surgery, including adapted physical activity sessions, therapeutic education workshops, and systematic referral to the department's DAPAP program.

The 2 groups in the trial

  • Control groupNo study treatment, for comparison

    The control group will consist of patients with bladder or kidney cancer receiving standard care, which includes a comprehensive assessment by an oncogeriatrician followed by surgery approximately 4 weeks later. Postoperatively, patients will be transferred to a rehabilitation center (SSR) for recovery, in line with standard clinical practice. As part of the study protocol, control group patients will undergo additional follow-up assessments alongside their usual care. These follow-ups-conducted at baseline, and at 1, 2, 3 months, and at the final endpoint-will mirror those of the intervention group. They will include patients- completed questionnaires and physical assessments conducted by an adapted physical activity teacher.

  • Interventional groupTreatment being tested

    The interventional group will consist of bladder and kidney cancer patients who will follow a personalized 6-month care pathway in addition to standard care. This pathway includes: * 2 adapted physical activity (APA) sessions per week for 4 weeks prior to surgery * 2 APA sessions/ week for 4 weeks following surgery * Therapeutic education workshops tailored to individual needs, covering topics as physical activity, nutrition, treatments, fatigue, and relaxation * Referral to the department's DAPAP for a 12-week "bridge program", consisting of one APA session per week. The study will be conducted in the oncogeriatrics departments of Saint-Etienne University Hospital and Loire Private Hospital.

    Treatment: APA, Therapeutic education workshops, and DAPAP

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer - FRAGECO - Multicenter, Controlled, Randomized Study
Plain-language title
Personalized 6-month programme for frailty in older people with bladder or kidney cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
9 December 2025